Medical Condition News

RSS

Research finds no increased risk of abnormal heart rhythms despite FDA warning against citalopram

The U.S. Food and Drug Administration's warning that high doses of the antidepressant citalopram can cause potentially serious abnormal heart rhythms might be doing more harm than good.

4 May 2013

Case report reveals that sugar substitutes may adversely affect endocrine health

It's a known fact that drinking too many sugary drinks can lead to obesity and diabetes, but sugar substitutes may adversely affect your endocrine health, according to a case report presented at the American Association of Clinical Endocrinologists 22nd Annual Scientific and Clinical Congress.

4 May 2013

Researchers identify genetic risk factor for persistent pain after traumatic events

A new study led by University of North Carolina School of Medicine researchers is the first to identify a genetic risk factor for persistent pain after traumatic events such as motor vehicle collision and sexual assault.

3 May 2013

New joint lubricant brings longer lasting relief to osteoarthritis sufferers

A team of researchers led by a Boston University Biomedical Engineer has developed a new joint lubricant that could bring longer lasting relief to millions of osteoarthritis sufferers.

3 May 2013

Gene mutation associated with rare sleep disorder also contributes to debilitating migraines

A gene mutation associated with a rare sleep disorder surprisingly also contributes to debilitating migraines, a new discovery that could change the treatment of migraines by allowing development of drugs specifically designed to treat the chronic headaches.

3 May 2013

Study: Gene mutations are associated with severe form of nearsightedness

People have long taken for granted that glasses and contact lenses improve vision for nearsightedness, but the genetic factors behind the common condition have remained blurry. Now researchers at Duke Medicine are closer to clearing this up.

3 May 2013

Newly discovered ‘master regulator’ gene may help develop novel treatment for drug-resistant tumors

Researchers at Johns Hopkins have identified a gene that, when repressed in tumor cells, puts a halt to cell growth and a range of processes needed for tumors to enlarge and spread to distant sites. The researchers hope that this so-called "master regulator" gene may be the key to developing a new treatment for tumors resistant to current drugs.

3 May 2013

New computational method for assessing lung cancer tumors

Moffitt Cancer Center and the University of South Florida have collaborated with researchers in China, the United Kingdom, the Netherlands and Germany to devise a new computational method for assessing lung cancer tumors using CT, PET or MRI diagnostic technologies.

3 May 2013

Regeneron Pharmaceuticals expands ophthalmology portfolio

Regeneron Pharmaceuticals, Inc. today announced that it has expanded its ophthalmology portfolio by acquiring full exclusive rights to two families of novel antibodies invented at Regeneron and previously included in Regeneron's antibody collaboration with Sanofi.

3 May 2013

Oregon study offers insights into reach of health law's Medicaid expansion

The landmark study, which was appears in The New England Journal of Medicine, analyzed data from the Oregon Health Study, which compared low-income people in that state who had access to Medicaid with a similar population that did not. The findings offer insights into how Medicaid coverage affects overall health and health costs.

3 May 2013

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, announced the issuance of a U.S. patent covering methods of treatment and formulations for its clinical-stage compound, 2-methoxyestradiol.

3 May 2013

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

Martindale Pharma, a leader in the manufacture and supply of specialty pharmaceuticals, is pleased to announce the UK launch of Prenoxad Injection, the world's first licensed emergency treatment for acute opioid related overdose for use at home or other non-medical settings.

3 May 2013

Study results suggest that restricting food intake increases reward value of food

The story is a familiar one: most people are able to lose weight while dieting but once the diet is over, the weight comes back. Many of us can personally attest that caloric deprivation weight loss diets typically do not produce lasting weight loss.

3 May 2013

Scientists spell out pivotal role of Peli1 in mouse model of multiple sclerosis

Scientists have identified an influential link in a chain of events that leads to autoimmune inflammation of the central nervous system in a mouse model of multiple sclerosis.

3 May 2013

Lund researchers develop new mouse model to better understand type 2 diabetes in humans

Researchers at Lund University in Sweden have developed a new mouse model that answers the question of what actually happens in the body when type 2 diabetes develops and how the body responds to drug treatment.

3 May 2013

EPAC2 and diabetes: an interview with Dr. Hussain, Johns Hopkins University

EPAC stands for exchange protein activated by cyclic AMP (cAMP). cAMP is an (among many) intracellular messenger molecule. cAMP is generated when certain hormones stimulate a cell by binding to their receptor, which is at the outside surface of the cell.

3 May 2013

Regional anesthesia improves outcomes in sleep apnea patients undergoing total joint arthroplasty

Using regional anesthesia instead of general anesthesia in patients with sleep apnea undergoing total joint replacement decreases major complications by 17%, according to a study published online, ahead of print, in the journal Regional Anesthesia and Pain Medicine.

3 May 2013

Weekend reading: Overweight doctors; ADHD diagnosis wars; States cut treatment for mentally ill; The war on breast cancer

Recently, a survey of three decades of screening published in November in The New England Journal of Medicine found that mammography's impact is decidedly mixed: it does reduce, by a small percentage, the number of women who are told they have late-stage cancer, but it is far more likely to result in overdiagnosis and unnecessary treatment, including surgery, weeks of radiation and potentially toxic drugs.

3 May 2013

Shore Medical Center inks affiliation agreement with The Cancer Institute of New Jersey

Shore Medical Center is pleased to announce it has entered into an affiliation agreement with The Cancer Institute of New Jersey - the state's only National Cancer Institute-designated Comprehensive Cancer Center.

3 May 2013

LBDA, FTD partner to launch first annual national LBD Flower Day campaign

The Lewy Body Dementia Association announced today that the organization is partnering with FTD to launch its first annual national "LBD Flower Day" campaign.

3 May 2013

Medical Condition News

Research finds no increased risk of abnormal heart rhythms despite FDA warning against citalopram

Case report reveals that sugar substitutes may adversely affect endocrine health

Researchers identify genetic risk factor for persistent pain after traumatic events

New joint lubricant brings longer lasting relief to osteoarthritis sufferers

Gene mutation associated with rare sleep disorder also contributes to debilitating migraines

Study: Gene mutations are associated with severe form of nearsightedness

Newly discovered ‘master regulator’ gene may help develop novel treatment for drug-resistant tumors

New computational method for assessing lung cancer tumors

Regeneron Pharmaceuticals expands ophthalmology portfolio

Oregon study offers insights into reach of health law's Medicaid expansion

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

Study results suggest that restricting food intake increases reward value of food

Scientists spell out pivotal role of Peli1 in mouse model of multiple sclerosis

Lund researchers develop new mouse model to better understand type 2 diabetes in humans

EPAC2 and diabetes: an interview with Dr. Hussain, Johns Hopkins University

Regional anesthesia improves outcomes in sleep apnea patients undergoing total joint arthroplasty

Weekend reading: Overweight doctors; ADHD diagnosis wars; States cut treatment for mentally ill; The war on breast cancer

Shore Medical Center inks affiliation agreement with The Cancer Institute of New Jersey

LBDA, FTD partner to launch first annual national LBD Flower Day campaign

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News